Anti-DAF, Recombinant [67]
Invented by Prof Nancy Hogg from Cancer Research UK London Research Institute: Lincoln's Inn Fields
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 152592 |
| Applications | FACS IHC IF WB |
| Antigen/Gene or Protein Targets | Decay accelerating factor (DAF, CD55) |
| Reactivity | Human |
| Relevance | Decay Accelerating Factor is a distinctive marker of synovium. Decay Accelerating Factor protects tissues from attack by autologous complement by interfering with the assembly of C3 convertase. |
| Host | Mouse |
| Immunogen | Fibronectin purified human monocytes . |
| Subclass | IgG1 |
| Formulation | PBS only |
| Concentration | 1mg/ml |
| Research Area | Cell Type or Organelle Marker, Immunology |
| Notes | Recombinant monoclonal antibody produced from the original monoclonal. Manufactured using Absolute Antibody’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma. |
References: 2 entries
Original hybridoma first published in Palmer et al. 1985. Clin Exp Immunol. 59(3):529-38. PMID: 3886218.
Features of synovial membrane identified with monoclonal antibodies.
Europe PMC ID: 3886218
Add a reference
References: 2 entries
Original hybridoma first published in Palmer et al. 1985. Clin Exp Immunol. 59(3):529-38. PMID: 3886218.
Features of synovial membrane identified with monoclonal antibodies.
Add a reference
